π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This study compares the effectiveness and safety of two different intralesi...
Status
Completed
Location
faculty of Medicine
Start Date
2024-09-01
Trial ID
NCT07307131
Apatinib, an oral inhibitor of vascular endothelial growth factor receptor ...
Status
Completed
Location
Hunan Cancer Hospital
Start Date
2020-03-12
Trial ID
NCT04322552
Treatments Being Tested
This study will assess the effects of savolitinib on the pharmacokinetics (...
Status
Completed
Location
Research Site
Start Date
2023-04-25
Trial ID
NCT05768360
Treatments Being Tested
Prospective, randomized, open-label clinical trial studying the treatment o...
Status
Unknown
Location
Our Lady of the Lake Regional Medical Center
Start Date
2019-09-16
Trial ID
NCT04092621
Efficacy Study of Digoxin Combined with Serplulimab and Chemotherapy in Fir...
Status
Not Yet Recruiting
Location
Anyang Cancer Hospital
Start Date
2025-08-01
Trial ID
NCT07025850
Treatments Being Tested
This is a study in healthy volunteers to assess the pharmacokinetics (PK) o...
Status
Completed
Location
Research Site
Start Date
2012-03
Trial ID
NCT01561781
Treatments Being Tested
Drug-drug interaction study between Bemnifosbuvir/Ruzasvir and Digoxin or R...
Status
Completed
Location
Atea Study Site
Start Date
2025-04-08
Trial ID
NCT06921941
A Phase I modular study to assess the effect of oral saruparib on other tre...
Status
Active Not Recruiting
Location
Research Site
Start Date
2025-03-25
Trial ID
NCT06899061
Treatments Being Tested
This study will treat patients with advanced NSCLC who have progressed foll...
Status
Completed
Location
Shandong Cancer Hospital (Shandong Provincial Institute of Cancer Prevention and Treatment)
Start Date
2023-07-31
Trial ID
NCT05926180
Treatments Being Tested
This is a Phase 1, open-label, two-period, one-sequence, crossover drug-dru...
Status
Completed
Location
Daytona Beach Clinical Rsch Unit
Start Date
2024-11-06
Trial ID
NCT06677957
Treatments Being Tested